Showing 1 - 8 results of 8 for search 'Junko S. Takeuchi', query time: 0.39s
Refine Results
-
1
Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA) by Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Junko S. Takeuchi, Yuki Takamatsu, Kenji Maeda, Ayako Mikami, Mugen Ujiie, Wataru Sugiura
Published 2022-06-01
Article -
2
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction. by Kei Yamamoto, Yusuke Ohsiro, Tetsuya Suzuki, Michiyo Suzuki, Sayaka Miura, Maki Nagashima, Noriko Iwamoto, Junko S Takeuchi, Moto Kimura, Wataru Sugiura, Satoru Nebuya, Masato Kurokawa, Norio Ohmagari
Published 2023-01-01
Article -
3
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction by Kei Yamamoto, Yusuke Ohsiro, Tetsuya Suzuki, Michiyo Suzuki, Sayaka Miura, Maki Nagashima, Noriko Iwamoto, Junko S. Takeuchi, Moto Kimura, Wataru Sugiura, Satoru Nebuya, Masato Kurokawa, Norio Ohmagari
Published 2023-01-01
Article -
4
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2 by Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki, Haruhito Sugiyama, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Published 2023-05-01
Article -
5
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study by Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Azusa Kamikawa, Yumiko Kito, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura
Published 2022-09-01
Article -
6
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave by Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Published 2023-03-01
Article -
7
An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine by Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura, Katsushi Tokunaga
Published 2022-04-01
Article -
8
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan by Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura
Published 2023-01-01
Article